STEVENS CAPITAL MANAGEMENT LP - AEGERION PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
STEVENS CAPITAL MANAGEMENT LP ownership history of AEGERION PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2016$60,000
-87.0%
16,329
+13.1%
0.00%
-83.3%
Q2 2014$463,000
+56.9%
14,439
+126.0%
0.01%
+50.0%
Q1 2014$295,0006,3890.01%
Other shareholders
AEGERION PHARMACEUTICALS INC shareholders Q2 2024
NameSharesValueWeighting ↓
ADVENT INTERNATIONAL, L.P. 447,001$14,344,000100.00%
Broadfin Capital, LLC 1,620,088$51,988,0002.56%
SCOPIA CAPITAL MANAGEMENT LP 2,899,585$93,048,0002.40%
Tamarack Capital Management, LLC 400,000$11,656,0002.38%
March Altus Capital Management LP 199,037$6,387,0002.34%
PRICE MICHAEL F 240,000$7,702,0000.94%
DELTEC ASSET MANAGEMENT LLC 106,151$3,406,0000.72%
WESTFIELD CAPITAL MANAGEMENT CO LP 3,207,598$102,932,0000.61%
CLOUGH CAPITAL PARTNERS L P 508,800$16,327,0000.52%
Catalyst Capital Advisors LLC 86,500$2,776,0000.45%
View complete list of AEGERION PHARMACEUTICALS INC shareholders